期刊
BLOOD
卷 104, 期 12, 页码 3804-3812出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2004-05-1850
关键词
-
类别
资金
- NCI NIH HHS [CA 102052-02] Funding Source: Medline
- NHLBI NIH HHS [R01 HL63452, HL55209, R01 HL66308, 2 R37 HL56067] Funding Source: Medline
- NIAID NIH HHS [R01 AI 34495] Funding Source: Medline
Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after bone marrow transplantation (BMT). CD4(+)CD25(+) immune regulatory T cells (Tregs), long recognized for their critical role in induction and maintenance of self-tolerance and prevention of autoimmunity, are also important in the regulation of immune responses in allogeneic bone marrow (BM) and solid organ transplantation. Published data indicate that ex vivo activated and expanded donor Tregs result in significant inhibition of lethal nor- or host-type LSel(hi), but not LSeIlo, Tregs potently increased donor BM engraftment in sublethally irradiated mice, an event occurring independently of transforming growth factor beta signaling of host T cells. These data indicate that Treg cellular therapy warrants clinical consideration for the inhibition of GVHD and the promotion of alloengraftment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据